How AI uncovers new ways to tackle difficult diseases
SMRTR summary
AI is revolutionizing drug discovery, potentially reducing development time and costs. At least 75 AI-discovered molecules have entered clinical trials, with companies like Insilico Medicine and Recursion Pharmaceuticals showing promising results in treating rare diseases and cancer using AI-driven approaches.
SMRTR provides this summary for quick context. The original article belongs to BBC News.
Read the original article